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Abstract
Background: Cryptococcus neoformans (C. neoformans) is a globally distributed fungal pathogen with
the potential to cause serious disease, particularly among immune compromised hosts. Exposure
to this organism is believed to occur by inhalation and may result in pneumonia and/or disseminated
infection of the brain as well as other organs. Little is known about the role of airway epithelial cells
in cryptococcal recognition or their ability to induce an inflammatory response.
Methods: Immortalized BEAS-2B bronchial epithelial cells and primary normal human bronchial
epithelium (NHBE) were stimulated in vitro with encapsulated or acapsular C. neoformans cultivated
at room temperature or 37°C. Activation of bronchial epithelial cells was characterized by analysis
of inflammatory cytokine and chemokine expression, transcription factor activation, fungal-host cell
association, and host cell damage.
Results: Viable C. neoformans is a strong activator of BEAS-2B cells, resulting in the production of
the neutrophil chemokine Interleukin (IL)-8 in a time- and dose-dependent manner. IL-8 production
was observed only in response to acapsular C. neoformans that was grown at 37°C. C. neoformans
was also able to induce the expression of the chemokine CXCL1 and the transcription factor
CAAT/enhancer-binding protein beta (CEBP/β) in BEAS-2B cells. NHBE was highly responsive to
stimulation with C. neoformans; in addition to transcriptional up regulation of CXCL1, these primary
cells exhibited the greatest IL-8 secretion and cell damage in response to stimulation with an
acapsular strain of C. neoformans.
Conclusion: This study demonstrates that human bronchial epithelial cells mediate an acute
inflammatory response to C. neoformans and are susceptible to damage by this fungal pathogen. The
presence of capsular polysaccharide and in vitro fungal culture conditions modulate the host
inflammatory response to C. neoformans. Human bronchial epithelial cells are likely to contribute
to the initial stages of pulmonary host defense in vivo.
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Background
Cryptococcus neoformans (C. neoformans) has been recog-
nized as an important emerging fungal pathogen through-
out the world during the past two decades [1]. Healthy
individuals frequently develop asymptomatic or mild
infection with C. neoformans while humans with impaired
host defenses may progress to severe pneumonia and
potentially fatal meningoencephalitis [2]. Natural infec-
tion is believed to occur via inhalation and is usually
caused by an encapsulated cryptococcal strain, although
recent investigations have reported similar clinical disease
caused by acapsular yeast forms [3,4]. The use of animal
models such as genetically engineered or naturally mutant
mice have shown that the protective host immune
response against C. neoformans requires type 1 helper T
(Th1)-cell mediated immunity characterized by activation
of CD4+ and CD8+ T cells and secretion of the Th1-related
cytokines gamma interferon (IFN-γ), IL-12, IL-18, and
tumor necrosis factor alpha (TNF-α) [5]. A variety of other
cell populations including B cells [6], natural killer (NK),
NKT, gamma-delta antigen receptor-bearing T (γδT) cells
[7] and dendritic cells [8] have also been implicated in the
host immune response against C. neoformans. Further-
more, several investigations have defined a major role for
lung alveolar macrophages in the initial host response
against C. neoformans [9,10]. While there is little doubt
that the alveolar macrophage is a key mediator of host
immunity against C. neoformans and other pulmonary
pathogens [11], the role of pulmonary epithelial cells in
resistance to cryptococcal infection has not been well-
characterized.
The lung epithelium represents much more than a simple
protective physical barrier between the external environ-
ment and underlying tissues. In fact, both constitutive and
inducible defense mechanisms of the airway lining are
now recognized as fundamental elements of an effective
antimicrobial environment [12]. The role of the airway
lining as a highly responsive and multifunctional inter-
face in the host innate immune response against various
microorganisms has been summarized in several recent
reviews [12,13]. C. neoformans has been shown to bind to
the A549 human alveolar cell line in a time- and temper-
ature-dependent manner, with apparent internalization
[14]. This report demonstrated that factors such as yeast
culture age and in vitro growth conditions influenced lung
epithelial cell binding by various strains of C. neoformans
and showed greater adherence to A549 cells in the
absence of a polysaccharide capsule [14]. Using the same
cell line, another group recently reported that purified
GXM, the major capsular component of C. neoformans,
could induce IL-8 secretion after binding to the CD14
receptor [15,16]. Finally, the multifunctional enzyme
secretory phospholipase B (PLB1) has also been shown to
play a role in the adhesion process of C. neoformans to the
alveolar epithelium [17]. To the best of our knowledge,
there have been no studies characterizing the interaction
between C. neoformans and cells of the airway lining that
represent a first site of contact for airborne pathogens.
Therefore, we investigated the ability of immortalized and
normal human bronchial epithelial cells to trigger a host
inflammatory response to viable C. neoformans. We found
that BEAS-2B cells produced the potent chemokine IL-8 in
an AP-1 and NF-κB dependent manner when stimulated
with acapsular C. neoformans. The presence of acapsular C.
neoformans also led to an increase in expression of the
chemokine CXCL1 as well as the transcription factor
CAAT/enhancer-binding protein beta (CEBP/β). Primary
Normal Human Bronchial Epithelial cells also secreted
more IL-8 and exhibited significantly greater cell damage
in response to acapsular C. neoformans compared to stim-
ulation with an encapsulated strain. Together these data
clearly demonstrate that airway epithelial cells mount a
strong inflammatory response to C. neoformans that is
modulated by the presence of the polysaccharide capsule.
Methods
Reagents and antibodies
F-12K nutrient mixture (Kaighn's modification), penicil-
lin/streptomycin, glutamine, and trypsin-EDTA were from
GIBCO Life Technologies, Ltd (Paisley, UK). Fetal calf
serum (FCS) was from Hyclone (Logan, UT). Human
recombinant TNF-α was from R&D systems (Minneapolis,
MN). Lipopolysaccharide (LPS) (E. Coli, O55:B5) and flu-
orescein isothiocyanate (FITC) were from Sigma
(Oakville, ON). Diff-Quik®  stain set was from Dade
Behring (Newark, DE).
C. neoformans strains
Wild type B3501, mutant CAP64, and 52D cryptococcal
strains (34873, 52816, and 24067, respectively) were
obtained from the American Type Culture Collection
(ATCC, Manassas, VA). CAP64 is an avirulent capsule-
deficient mutant [18,19] derived from the parental labo-
ratory strain B3501. Strain 52D is a moderately virulent
clinical isolate from human cerebrospinal fluid. Capsular
and acapsular forms of C. neoformans were grown and
maintained on Sabouraud dextrose agar (BD, Sparks,
MD). For cell stimulation, a single colony suspension in
Sabouraud dextrose broth (BD, Sparks, MD) was prepared
and grown to early stationary phase (48 h) at room tem-
perature or 37°C with continuous rotation. The culture
was then washed with PBS, counted on a hemacytometer,
and diluted to the desired concentration in cell culture
media.
Cells and culture conditions
The BEAS-2B human tracheobronchial epithelial cell line
was obtained from the ATCC (CRL-9609) and cultured as
described previously [20]. For stimulation experiments,Respiratory Research 2008, 9:9 http://respiratory-research.com/content/9/1/9
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cells were seeded at 2 × 105 cells on 12-well plates (Costar,
New York, NY) and grown at 37°C in 5% CO2. Forty-eight
hours later, cells were washed once and triplicate wells
were stimulated with various multiplicities of infection
(MOI) as described in the figure legends. NHBE (Normal
Human Bronchial Epithelial) cells from Cambrex (Walk-
ersville, MD) were maintained at 37°C and 5% CO2 and
subcultured in Bronchial Epithelial Growth Medium
(BEGM) as recommended by the manufacturer. For stim-
ulation, NHBE were seeded at 10000 cells/cm2 in 12-well
plate (Costar). Forty-eight hours later, cells were counted
and triplicate wells were stimulated with an MOI of 20 of
acapsular CAP64 or capsular 52D C. neoformans.
RT-PCR
Total RNA was extracted using an RNeasy kit (Qiagen,
Mississauga). Reverse transcription (RT) was performed
with 0.5 μg of total RNA that had been extracted, using the
ABI high capacity cDNA archive kit (ABI, Foster City, CA).
PCR was performed using specific primers (AlphaDNA,
Montreal, QC) for human CEBP/β (sense: 5'-GAC AAG
CAC AGC GAC GAG TA-3'; antisense: 5'-AGC TGC TCC
ACC TTC TTC TG-3' – amplicon size 158 bp), CXCL-1
(sense: 5'-AGG GAA TTC ACC CCA AGA AC-3'; antisense:
5'-CAC CAG TGA GCT TCC TCC TC-3' – amplicon size
204 bp), CCL2 (sense: 5'-TCC AGC ATG AAA GTC TCT
GC-3'; antisense: 5'-TGG AAT CCT GAA CCC ACT TC-3'-
amplicon size 265 bp); the CCL15 primer set was
obtained from SuperArray – amplicon size 150 bp. As an
internal control, we used primers for the detection of
human β-actin (sense 5'-AAG GAG AAG CTG TGC TAC
GTC GC-3'; antisense 5'-AGA CAG CAC TGT GTT GGC
GTA CA-3' – amplicon size 266 bp [20]). PCR amplifica-
tions were performed in a Peltier thermal cycler apparatus
(MJ Research, Watertown, MA) using the Amplitaq
polymerase (ABI, Foster City, CA). For the detection of
CEBP/β, CXCL1 and CCL2 the thermocycling protocol
was: 95°C for 1 min, 30 cycles of denaturation at 95°C for
45 s, annealing at 56°C for 45 s, and extension at 72°C for
1 min. For the detection of CCL15, 34 cycles were applied;
for the detection of β-actin, 24 cycles were applied. Ampli-
fication products were resolved on a 1.5% agarose gel con-
taining ethidium bromide and recorded with a Gene
Genius bioimaging system (Syngene, Frederick, MD). Dif-
ferent cycle numbers for each target were performed to
verify that each PCR product was analyzed during the
exponential phase of the amplification reaction.
Real time PCR
Real-time PCR was performed using an ABI Prism 7500
Real time PCR System (Applied Biosystems, Foster City,
CA). Each reaction contained 10 μl of 2× platinum® SYBR®
Green PCR Supermix (including Platinum® Taq polymer-
ase, SYBR® green dye, Tris-HCL, KCL, 6 mM MgCl2, 400
μM dATP, 400 μM dCTP, 400 μM dGTP, 800 μM dUTP,
Uracil DNA glycosylase (UDG) and stabilizers) (Invitro-
gen, Carlsbad, CA), 0.04 μl of ROX reference dye, 0.2 μM
of each of forward and reverse primers (same as described
above), and 25 ng of cDNA as template in a final volume
of 20 μl. Reactions were incubated at 50°C for 2 min fol-
lowed by 95°C for 10 min. The amplification profile was
15 s denaturation at 95°C followed by 40 s annealing at
60°C for a total of 40 cycles. Then a dissociation curve was
realized to analyze the specificity of the reaction and the
amplification of the expected single products was con-
firmed on 1.5% agarose gels stained with ethidium bro-
mide (data not shown). Data were analyzed with the
comparative Ct method (ΔΔCt) outlined in the ABI user
manual with the 7500 system SDS software (Applied Bio-
systems). For the relative quantification, the amount of
the targets CCL2, CXCL1 and CEBP/β were normalized to
β-actin (endogenous gene) relative to unstimulated cells
used as the calibrator and calculated using 2-ΔΔCtCt.
Analysis of C. neoformans binding
BEAS-2B cells were seeded at 2 × 105 on individual cover-
slips (Fisher scientific, Pittsburg, PA) in a 12-well plate
and stimulated with C. neoformans as indicated in the fig-
ure legends. Twenty-four hour later, cells were washed
twice with PBS and then stained with Diff-Quik® products.
Slides images were captured with a Retiga 1300 C digital
camera (QImaging Corp., Burnaby, BC) attached to a
Zeiss AxioSkop II (Carl Zeiss Canada Ltd., Toronto, ON)
light microscope.
Fluorescence Activated Cell Sorter (FACS) Analysis
BEAS-2B cells were seeded at 2 × 105 on 12-well plates and
grown for 48 h. Fluorescently labeled C. neoformans was
prepared by incubation with 0.5 mg/ml FITC for 10 min-
utes, followed by three washes with PBS, as previously
described [21]. BEAS-2B cells were incubated with C. neo-
formans  for 3 hours, then washed twice with PBS, and
trypsinized. Cells were subsequently incubated in the
presence or absence of the extracellular dye quencher
Trypan blue (200 μg/ml), washed three times with PBS,
and their fluorescence was analyzed using a FACScalibur
(BD Biosciences, San Jose, CA).
Epithelial cell transfection and reporter gene studies
BEAS-2B cells were seeded at 7 × 104 on 24 well plates (Cos-
tar) 24 h before transfection using FuGENE 6 transfection
reagent (Roche Molecular Diagnostics, Indianapolis, IN)
according to the manufacturer's instructions. Cells were
transfected with 200 ng of -133-luc, NFκB mutated-luc and
AP-1-mutated-luc IL-8 luciferase constructions described
elsewhere [22]. After 48 h, cells were left untreated or stim-
ulated for 6 h with a MOI of 20 of acapsular C. neoformans
or 20 ng/ml of TNF-α. Cell lysates were obtained by treat-
ment with passive lysis buffer and firefly luciferase activity
was measured as described previously [20], using a LmaxRespiratory Research 2008, 9:9 http://respiratory-research.com/content/9/1/9
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(Molecular Devices, Sunnyvale, CA) apparatus. Results are
expressed as relative luciferase units (RLU).
Gene Expression Array Studies
Human cytokine and receptor microarrays profiling a
total of 113 cytokines, chemokines, and the correspond-
ing receptor genes involved in the inflammatory response
(Oligo GEArray® OHS-011, SuperArray, Bethesda, MD)
were used to evaluate the gene expression profile of BEAS-
2B cells stimulated with C. neoformans. Total cellular RNA
(0.8  μg) was used as the template to produce biotin-
labeled amplified cRNA; subsequent hybridization of the
microarrays was performed with 3 μg of biotin labeled
cRNA. Microarray analysis was performed as manufac-
turer's recommendations. An image of each array was
taken and saved using a Gene Genius bioimaging system
(Syngene) followed by analysis using the GEArray Expres-
sion analysis software. The relative amount of each target
gene transcript was estimated by comparing its signal
intensity with the signal derived from two housekeeping
genes (β-actin, GAPDH).
Cytokine and LDH measurements
The levels of human IL-8 and lactate dehydrogenase
(LDH) in cell culture supernatants were determined using
a DuoSet ELISA kit (R&D systems, Minneapolis, MN) and
a LDH assay kit (CytoTox 96® Non-radioactive cytotoxicity
assay, Promega, Madison, WI), respectively.
Statistical Analysis
Each point corresponds to the mean ± S.D. of the indi-
cated number of experiments. The statistical significance
of single comparisons was analyzed using the unpaired
Student's t test with a threshold of P ≤ 0.05. For multiple
comparisons, statistical significance was determined by a
one-way ANOVA with post-test comparisons using the
Tukey test with a threshold of P ≤ 0.05.
Results
Acapsular C. neoformans stimulates IL-8 production by 
BEAS-2B cells
To determine whether airway epithelial cells are able to
mediate an anti-cryptococcal response, we measured IL-8
protein secretion by human BEAS-2B following in vitro
stimulation with viable C. neoformans. In accordance with
a previous study that demonstrated capsule- and temper-
ature-dependent adhesion of C. neoformans to human
alveolar epithelium [14], both encapsulated and unen-
capsulated yeast forms were grown at room temperature
(RT) as well as 37°C prior to cell stimulation. All yeast cul-
tures were grown to late log phase prior to use. The in vitro
growth kinetic of C. neoformans was comparable between
the encapsulated and unencapsulated forms; however,
higher growth rates for both strains were achieved at room
temperature (data not shown). Stimulation of BEAS-2B
cells with the encapsulated B3501 strain did not induce
significant release of IL-8, regardless of whether it was
grown at RT (Figure 1A) or 37°C (data not shown). The
same results were also observed following stimulation of
BEAS-2B with the encapsulated 52D strain grown at RT
and 37°C (data not shown). In contrast, acapsular C. neo-
formans cultured at 37°C triggered substantial secretion of
IL-8 in a concentration- (Figure 1B) and time- (Figure 1C)
dependent manner in BEAS-2B cells. The amount of IL-8
secretion was significantly increased with a MOI of 20 or
greater (Figure 1B); this was observed by 6 h post-stimula-
tion and accumulated in the culture medium for up to 24
h (Figure 1C). No IL-8 production was observed in
response to acapsular C. neoformans that had been cul-
tured at RT (Figure 1D).
Acapsular C. neoformans binds and tightly associates 
with BEAS-2B cells
Light microscopy of differentially stained co-cultures was
used to characterize the interaction between C. neoformans
and BEAS-2B cells. After washing and staining, a stable
association of acapsular C. neoformans grown at RT or
37°C with BEAS-2B cells was observed (Figure 2). Inter-
estingly, prominent in vitro aggregation of acapsular C.
neoformans  was observed when grown at 37°C (Figure
2E). The yeast-host cell interaction was resistant to
trypsinization and appeared to be confined to the cell sur-
face without evidence of internalization (Figure 2I). Con-
versely, no yeast-epithelial cell association was evident for
the encapsulated form of C. neoformans (data not shown).
A previously established technique to analyze the associa-
tion and uptake of serotype A C. neoformans by human
peripheral blood monocytes was then used to examine
whether acapsular C. neoformans could be internalized by
BEAS-2B cells [21]. We initially confirmed the efficacy of
trypan blue to quench fluorescently labeled acapsular C.
neoformans; FITC-labeled C. neoformans cells were homog-
enously fluorescent (99.5%) and this signal was almost
completely eliminated (97.5%) by 200 μg/ml of trypan
blue (data not shown). Incubation of BEAS-2B cells with
FITC-labeled acapsular C. neoformans grown at RT or 37°C
led to an increase in fluorescence (FL1-H) for 7.5% and
10.4% of BEAS-2B cells grown at RT or 37°C (Figure 2C
and 2G, respectively). Following trypan blue treatment of
BEAS-2B cells complexed with C. neoformans grown at RT,
clear inhibition of the mean fluorescence intensity was
observed (66.9% ± 4.5%; Figure 2D) and only 0.9% of
cells retained the fluorescent label. This observation indi-
cates that C. neoformans grown at RT is able to bind BEAS-
2B cells but remains accessible to the quenching reagent.
Comparable inhibition of the mean fluorescence intensity
was observed following trypan blue treatment of BEAS-2B
cells complexed with C. neoformans grown at 37°C (78.9
± 0.7%; Figure 2H) however, 6.8% of BEAS-2B cells
retained the fluorescent label, indicating that a small frac-Respiratory Research 2008, 9:9 http://respiratory-research.com/content/9/1/9
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tion of acapsular C. neoformans grown at 37°C is inacces-
sible to quenching by trypan blue.
Acapsular C. neoformans induces mild LDH release from 
BEAS-2B cells
To determine whether C. neoformans is able to induce dam-
age of bronchial epithelial cells, release of the intracellular
enzyme LDH was measured following incubation of BEAS-
2B cells with viable C. neoformans for 24 hours. As shown
in Figure 3, acapsular C. neoformans grown at RT or 37°C
induced a relatively small amount of LDH release by BEAS-
2B cells (7 ± 7.1% and 12 ± 6.7%, respectively) that is
indicative of mild cytotoxicity compared to cells that were
completely lysed with Triton (100%). To confirm the
validity of the assay using a relevant biological stimulus,
BEAS-2B cells were also incubated with a high dose of
TNFα (50 ng/ml), an inflammatory cytokine that is known
to induce cell cytotoxicity [23]. As expected, TNFα induced
substantial LDH release (35 ± 13.6%) by BEAS-2B cells.
IL-8 activation in BEAS-2B cells largely involves the 
transcription factor AP-1 and NF-κB
Activation of transcription factors is required in many sig-
nal transduction pathways. For instance, IL-8 production
can be activated in response to many different infectious
or inflammatory conditions and is largely dependent on
the transcription factor NF-κB and/or AP-1 [24]. To con-
firm whether these two signaling mechanisms are active in
bronchial epithelial cells upon in vitro stimulation with C.
neoformans, we examined IL-8 promoter activation using
luciferase reporter plasmids bearing engineered mutations
of either transcription factor-binding site. Consistent with
the data obtained by ELISA, we detected IL-8 luciferase
activity 6 h after stimulation with acapsular C. neoformans
in BEAS-2B cells transfected with a wild-type IL-8 luci-
ferase plasmid (-133-luc) (Figure 4A). A clear reduction of
inducible IL-8 luciferase activity was observed following
transfection of BEAS-2B cells with IL-8 reporter constructs
mutated at the AP-1 (AP-1 mut-luc) or NF-κB (NF-κB mut-
Acapsular C. neoformans induces IL-8 production by BEAS-2B cells in a dose, time, and temperature dependent manner Figure 1
Acapsular C. neoformans induces IL-8 production by BEAS-2B cells in a dose, time, and temperature dependent manner. (A) 
BEAS-2B cells were unstimulated (NS, white box) or stimulated (black box) for 24 h with various MOI (100, 50, 20, 10, 1) of C. 
neoformans B3501 cultured at RT; LPS (1 μg/ml) was used as a positive stimulus. B) BEAS-2B cells were untstimulated (NS, 
white box) or stimulated for 24 h with various MOI (50, 20, 10, 5 and 1) of acapsular C. neoformans. C) BEAS-2B cells were 
stimulated with acapsular C. neoformans (MOI of 20) for 6 h and 24 h. (D) BEAS-2B cells were stimulated for 24 h with acapsular 
C. neoformans (MOI of 20) grown at 37°C or RT. The cell supernatants were collected and ELISA was used to measure IL-8 
concentrations. All results are expressed as the mean ± S.D. of triplicate measurements and are representative of three inde-
pendent experiments; *P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001 relative to NS.
AB
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luc) binding sites (Figure 4A). Under these conditions we
also observed an inhibition of basal IL-8 luciferase activity
in unstimulated wells which is consistent with the obser-
vation that BEAS-2B cells constitutively release a detecta-
ble amount of IL-8 protein (Figure 1). To confirm the
specificity of the mutated plasmid constructs, TNFα-
induced stimulation of IL-8 reporter activity in BEAS-2B
cells was performed as a positive control for IL-8 induction
[24]. Consistent with previous reports using airway epi-
thelial cells, we observed strong IL-8 luciferase activity in
response to TNFα that was primarily dependent on NF-κB
with a minor contribution of AP-1 [25] (Figure 4B).
C. neoformans induces expression of the chemokine 
CXCL1 and the transcription factor CEBP/β in BEAS-2B cells
To further characterize the activation profile of bronchial
epithelial cells by C. neoformans, we used an oligonucle-
otide microarray in order to examine the induction of a
panel of 113 inflammatory cytokines, chemokines, and
their receptors (a complete list of genes represented on the
microarray is available on request). In unstimulated cells,
we observed constitutive expression of C3, C4A, CXCL-10,
MIF and TNFR1A that was not significantly influenced by
C. neoformans stimulation (Figure 5A). Twenty-four
hours after stimulation with acapsular C. neoformans, we
observed the induction of IL-8, as expected, as well as up-
regulation of CCL2, CXCL1, CCL15, and CEBP/β (Figure
5A and 5B). To validate these observations, we analyzed
the expression of CXCL1, CCL2, and CEBP/β, and CCL15
by qualitative and real-time PCR. As shown in Figures 6C
and 6D, we confirmed modest up-regulation of CXCL-1
and CEBP/β, but not CCL2, in C. neoformans stimulated
cells compared to untreated BEAS-2B cells. Surprisingly,
we were not able to demonstrate the expression of CCL15
Acapsular C. neoformans binds and is internalized by BEAS-2B cells Figure 2
Acapsular C. neoformans binds and is internalized by BEAS-2B cells. Light microscopy of differentially stained BEAS-2B cells that 
were stimulated for 24 h with acapsular C. neoformans cultured at RT (A), 37°C (E), or 37°C followed by trypsinization (I). Flow 
cytometric analysis of BEAS-2B cells that were stimulated for 3 h with unlabeled (B and F) or FITC-labeled (C and G) acapsular 
C. neoformans grown at RT or 37°C respectively, and then quenched with trypan blue (D and H). Data are representative of 
three independent experiments.
AB C D
Acapsular
C. neoformans
Acapsular
FITC-C. neoformans
Acapsular
FITC-C. neoformans
+ Quenching
Acapsular
C. neoformans
RT
37°C
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either in unstimulated or C. neoformans-stimulated BEAS-
2B cells by RT-PCR; nevertheless, we were able to weakly
amplify CCL15 using a human reference cDNA as a posi-
tive control (kindly provided by SuperArray; data not
shown). The integrity of all RNA preparations was verified
by RT-PCR analysis of β-actin expression.
C. neoformans is able to activate and damage primary 
NHBE cells
To exclude the possibility that IL-8 secretion and LDH
release by BEAS-2B cell line in response to C. neoformans
was a consequence of the viral immortalization process,
we studied the response of primary NHBE cells to stimu-
lation with an encapsulated or acapsular strain of C. neo-
formans. To more closely model conditions of authentic
infection, a moderately virulent encapsulated clinical iso-
late, strain 52D, was used to stimulate primary cells. The
NHBE cells used in this study were derived from a single
male donor and had been extensively tested to exclude the
presence of infectious agents. Interestingly, NHBE cells
were highly responsive to C. neoformans and produced a
significant amount of IL-8 in response to all conditions
tested in comparison to NS (Figure 6A). Consistent with
the observations using BEAS-2B cells, the maximal IL-8
secretion by NHBE cells was elicited by acapsular C. neo-
formans. In contrast to the BEAS-2B cell line, primary
NHBE were activated by both acapsular and capsular C.
neoformans, regardless of whether they were grown at RT or
at 37°C. Nevertheless, we observed that the capsular C.
neoformans grown at 37°C induced significantly lower IL-
8 secretion in comparison to the acapsular strain grown at
RT or 37°C. In contrast, capsular C. neoformans grown at
RT elicited significantly lower IL-8 secretion only in com-
parison to acapsular C. neoformans grown at 37°C. NHBE
cells were also highly susceptible to damage following a
24-hour incubation with viable C. neoformans. As shown
in figure 6B, acapsular C. neoformans grown at 37°C
induced the most significant LDH release by NHBE cells
(44.6 ± 5%) in comparison to all other conditions, includ-
ing the level elicited by acapsular C. neoformans grown at
RT (17.6 ± 7%). Notably, capsular C. neoformans grown at
RT or 37°C induced a relatively low amount of LDH
IL-8 activation by acapsular C. neoformans is dependent on  NF-κB and AP-1 Figure 4
IL-8 activation by acapsular C. neoformans is dependent on 
NF-κB and AP-1. BEAS-2B cells were transiently transfected 
in duplicate with 200 ng of luciferase reporter plasmid DNA 
bearing the wild type IL-8 promoter (-133-luc), or mutations 
(mut) of its AP-1 (AP-1-mut-luc) or NF-κB (NF-κB-mut-luc) 
binding sites. After overnight incubation, cells were left 
untreated (white columns) or stimulated (black columns) for 
6 h with acapsular C. neoformans (MOI = 20) (A) or TNF-α 
(20 ng/ml) (B). Cell lysates were collected and assayed for 
luciferase activity expressed as relative luciferase units (RLU). 
Data are shown as the mean ± S.D. Results are representa-
tive of three independent experiments.
A
B
Acapsular C. neoformans induces mild LDH release by BEAS- 2B cells Figure 3
Acapsular C. neoformans induces mild LDH release by BEAS-
2B cells. BEAS-2B cells were left untreated (NS, white box) 
or stimulated for 24 h with a MOI = 20 of acapsular C. neofor-
mans grown at RT or 37°C or 50 ng/ml of TNF-α. Superna-
tants were collected and assayed for LDH release using 
colorimetry. Data represent the mean ± S.D. of triplicate 
measurements from two independent experiments and are 
expressed as a percentage of LDH release from unstimulated 
BEAS-2B cells treated with a detergent lysis solution (triton).Respiratory Research 2008, 9:9 http://respiratory-research.com/content/9/1/9
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release from NHBE cells (1.6 ± 0.65% and 4.3 ± 1.2,
respectively). Finally, we examined transcriptional up reg-
ulation of CXCL1 and CEBP/β by C. neoformans in NHBE
cells. Using real-time PCR, we observed a 2- to 3-fold
induction of CXCL1 gene expression in NHBE by both
capsular and acapsular C. neoformans grown at RT or 37°C
(Figure 6C); however, no clear induction of CEBP/β was
demonstrable under any of the experimental conditions
used (Figure 6D).
Discussion
It is clearly established that humans acquire C. neoformans
infection from the environment, most likely through the
inhalation of dehydrated or poorly encapsulated yeast
particles termed infectious propagules. A high serologic
prevalence in certain geographic regions despite low clin-
ical infection rates suggests that in many cases the initial
infection is mild or completely asymptomatic [26]. In the
human lung, the host response to C. neoformans is pre-
BEAS-2B cells induce chemokine gene expression in response to stimulation with acapsular C. neoformans Figure 5
BEAS-2B cells induce chemokine gene expression in response to stimulation with acapsular C. neoformans. (A) BEAS-2B cells 
were left unstimulated (NS) (left panel) or stimulated (right panel) with acapsular C. neoformans MOI = 20 cultured at 37°C. 
Twenty-four hours later, RNA was extracted and analyzed by microarray for expression of inflammatory cytokines and their 
receptors. A box indicates the location of endogenous control (housekeeping) genes; glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) and beta-2 microglobulin (B2M) were used for normalization. (B) Summary of relative gene expression follow-
ing stimulation with C. neoformans. Data shown is representative of three independent experiments. *Not determined due to 
undetectable IL-8 expression in untreated cells. (C) Expression of CCL2, CXCL1, and CEBP/β was analyzed by RT-PCR; β-
actin was used as an endogenous control. (D) Relative quantification of CXCL1, CCL2, and CEBP/β expression in untreated 
(white columns) and stimulated (black columns) BEAS-2B cells was determined by real time PCR. Results are representative of 
three independent experiments.
A
C. neoformans NS
B
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CXCL-10
MIF
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CEBP/β CXCL-1
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IL-8
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GAPDH
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D
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β β β β-actin (266 bp)
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sumed to start with alveolar macrophage activation, fol-
lowed by the release of cytokines and chemokines that
recruit inflammatory cells to the site of infection. In order
for this interaction to occur, C. neoformans must transit the
airways prior to reaching the alveolus, yet the responsive-
ness and contribution of the airway epithelium to host
defense against cryptococcal infection is not well under-
stood. The cells that line these passages have been increas-
ingly recognized as an essential component of the host
immune response [12,27]. The current study has shown
that the interaction of C. neoformans with bronchial epi-
thelial cells activates the expression of both transcription
factors and chemokines that have well-established roles in
host defense.
As an initial step in the investigation of human lung epi-
thelial responses to viable C. neoformans, we selected the
SV-40 immortalized BEAS-2B bronchial epithelial cell line
that is derived from normal human tissue and capable of
microbial recognition [13,28,29]. For a primary measure
of cell activation, we quantified the secretion of IL-8, a
prototypical neutrophil chemokine. Interestingly, we
observed significant IL-8 secretion only when the BEAS-
2B cell line was stimulated with an acapsular form of C.
neoformans. Acapsular cryptococci exhibited a stable asso-
ciation with BEAS-2B cells that was resistant to enzymatic
treatment with trypsin as well as various physical manip-
ulations including washing and centrifugation of cell cul-
tures. The well known anti-phagocytic and
immunomodulatory properties of the polysaccharide cap-
sule [3] are a plausible explanation for the absence of sig-
nificant IL-8 release by BEAS-2B cells following
stimulation with encapsulated C. neoformans, as well as
the lack of visible fungal-host cell association under these
conditions. In addition to the acapsular state, we observed
that C. neoformans must be grown in vitro at 37°C in order
to elicit IL-8 secretion by BEAS-2B cells. Environmental
cues including temperature are well-known regulators of
C. neoformans signal transduction that in turn influence
microbial growth as well as virulence in animal models
[30,31]. These data suggest that one or more temperature-
regulated microbial factors distinct from GXM are
required for activation of BEAS-2B cells. Alternatively, the
in vitro cell aggregation that was observed at 37°C may
also have contributed to the activation of BEAS-2B cells,
possibly through coalescence or cross-linking of crypto-
coccal host cell surface receptors. This in vitro phenome-
non has also been described for various other strains of C.
neoformans  [32-35] and has been associated with
increased adherence as well as phagocytosis by mouse
macrophages [34]. On the basis of these initial observa-
tions, we chose to focus subsequent investigations on the
interaction of BEAS-2B cells with acapsular C. neoformans.
Internalization of C. neoformans by the A549 alveolar cell
line has been demonstrated by two previous studies
[14,15]. In one case, host cell damage following internal-
ization of an encapsulated serotype A clinical isolate was
also documented [15]. To determine whether BEAS-2B
bronchial epithelial cells are also capable of fungal inter-
nalization, we first examined differentially stained co-cul-
tures of C. neoformans and BEAS-2B cells by light
microscopy. Despite the stable fungal-host cell interaction
described above, no clear evidence of fungal internaliza-
NHBE cells induce chemokine expression and are susceptible  to damage following stimulation with C. neoformans Figure 6
NHBE cells induce chemokine expression and are susceptible 
to damage following stimulation with C. neoformans. (A) 
NHBE cells were left unstimulated (NS, white box) or stimu-
lated with a MOI = 20 of capsular or acapsular C. neoformans 
cultured at RT or 37°C, as indicated. Twenty-four hours 
later, supernatants were collected and ELISA was used to 
measure IL-8 concentrations. Results are expressed as the 
mean ± S.D. of triplicate measurements and are representa-
tive of three independent experiments. (B) Supernatants 
were also assayed for LDH release using colorimetry. Data 
are expressed as a percentage of LDH release from unstimu-
lated cells treated with a detergent lysis solution (triton) and 
represent the mean ± S.D. of triplicate measurements from 
two independent experiments. (C, D) Relative quantification 
of CXCL1 and CEBP/β expression was determined by real 
time PCR. Results are representative of the mean ± S.D. of 
one experiment performed in triplicate; δ P ≤ 0.05 vs. NS, * P 
≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001.
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tion was directly visible. We then used a more sensitive
flow cytometry technique combined with quenching of
trypan blue dye to examine the interaction of BEAS-2B
cells with FITC-labeled acapsular C. neoformans [21]. A
clear increase in mean fluorescence intensity of BEAS-2B
cells was observed following incubation with labeled
cryptococci that were grown at 20° or at 37°C, verifying
stable fungal binding in both conditions. The observation
that only a minority of cells exhibited an increase in fluo-
rescent signal may be attributable to partial disruption of
fungal-host cell interactions by the washing, trypsiniza-
tion, and centrifugation steps used to prepare the sample
for cytometry. Quenching of fluorescence was almost
complete for cryptococci grown at 20°C, a finding that is
indicative of an extracellular fungal location. Interest-
ingly, the residual fluorescence observed with fungi grown
at 37°C indicates that they were either very tightly associ-
ated with the cell surface or may have been internalized by
BEAS-2B cells. The extent of this process appeared to be
quite limited as only a small percentage of fungi retained
the trypan blue label. Further studies using a more
detailed direct visualization technique such as electron
microscopy will be required to confirm and discriminate
between these two possibilities. Finally, limited damage
of BEAS-2B cells by acapsular C. neoformans grown at
20°C or 37°C was observed by measurement of the intra-
cellular enzyme LDH in cell supernatants following co-
incubation.
In order to identify the signaling pathways that mediate IL-
8 release by BEAS-2B cells in response to cryptococci, we
performed transient transfections of a luciferase reporter
plasmid downstream of the wild type human IL-8 pro-
moter or engineered constructs bearing mutations of the
NF-κB or AP-1 transcription factor binding sites. Compared
to the wild type promoter sequence, luciferase activity was
reduced for each of the mutant plasmids, demonstrating a
role for both of these transcription factors in the up-regula-
tion of IL-8 by C. neoformans. These observations are con-
sistent with known regulation of IL-8 by other microbial
pathogens [24]. We also detected up-regulation of several
other inflammatory genes by C. neoformans in human
BEAS-2B cells using an oligonucleotide microarray and
confirmed the hybridization data by conventional and real-
time PCR for CXCL1 and CEBP/β. CXCL1 has already been
shown to be involved in leukocyte recruitment in mouse
models of C. neoformans infection [36], indicating that acti-
vation of this chemokine is likely to be conserved between
mice and humans. CEBP/β is expressed by alveolar and
bronchial epithelium and is particularly involved in acute
lung injury [37]. Interestingly, CEBP/β is also known to
bind the IL-8 promoter in lung epithelial cells and activate
transcription in a cooperative manner with NFκB [38].
Therefore, in addition to NF-κB and AP-1, CEBP/β activa-
tion in BEAS-2B cells upon stimulation with C. neoformans
may also contribute to the up-regulation of IL-8 expression.
In order to confirm the authenticity of the observations
that were obtained using BEAS-2B cells, we studied the
effect of viable C. neoformans on primary NHBE cells that
had not been subject to viral immortalization or serial in
vitro  passage. We found that primary NHBE cells were
highly responsive to stimulation with C. neoformans. Spe-
cifically, for all experimental conditions tested (capsular
or acapsular strains grown either at RT or 37°C), C. neofor-
mans was able to stimulate the secretion of IL-8 and the
expression of CXCL1 by NHBE. The highest level of IL-8
secretion was observed in response to acapsular C. neofor-
mans grown in vitro at 37°C. At the mRNA level, CXCL1
expression did not appear to be influenced by in vitro
growth conditions; however, this result does not exclude
the possibility that both IL-8 and CXCL1 protein expres-
sion are coordinately regulated in response to C. neoform-
ans  stimulation. The confirmation of IL-8 protein
secretion and CXCL1 up-regulation in NHBE strongly sug-
gests that human bronchial epithelium recognizes C. neo-
formans  and is capable of activating an in vivo host
inflammatory response. Despite the observation that
NHBE appeared to be responsive to capsular C. neoform-
ans, growth of this organism at 37°C significantly dimin-
ished the magnitude of IL-8 secretion, suggesting that
primary human epithelial cells respond to temperature
dependent changes in fungal metabolism. Primary NHBE
were also most susceptible to the cytotoxic effect of C. neo-
formans, especially when stimulated with the acapsular
form that had been cultured at 37°C. Encapsulated C. neo-
formans elicited very little LDH from NHBE compared to
acapsular form, regardless of whether it was cultivated at
room temperature or 37°C. The fact that both chemokine
activation and cell damage were reduced in the presence
of the cryptococcal polysaccharide capsule points to an
immunomodulatory role for GXM at the airway lining. It
is tempting to speculate that following cryptococcal inha-
lation, induction of the GXM polysaccharide capsule
expression in response to a change from ambient environ-
mental conditions to human body temperature could
facilitate the initial stage of fungal growth in the airways
by modifying or diminishing the inflammatory response
of the bronchial epithelium. Although the precise mecha-
nism by which capsule alters the host response is not
known, one possibility is that the presence of GXM
polysaccharide modulates the interaction of cryptococcal
surface or secreted structures with the bronchial epithe-
lium. This relative suppression of host immunity medi-
ated by C. neoformans might, in some cases, favor the
development of progressive pulmonary infection. Finally,
the observation that IL-8 secretion and cell damage were
greatest for NHBE at 37°C also suggests that C. neoformansRespiratory Research 2008, 9:9 http://respiratory-research.com/content/9/1/9
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expresses unidentified, temperature-regulated structures
potentially involved in pathogenesis.
Our data clearly demonstrate that both the immortalized
BEAS-2B cell line and primary NHBE cells are activated by
C. neoformans. Using either cell source, acapsular C. neofor-
mans grown at 37°C elicited the maximal secretion of IL-
8 and induced the greatest degree of cell damage. Tran-
scriptional up regulation of CXCL1 was also exhibited by
primary and immortalized cells in response to C. neoform-
ans. The NHBE cells used in our report were somewhat
more permissive to IL-8 secretion by encapsulated C. neo-
formans compared to BEAS-2B cells that were only acti-
vated by acapsular C. neoformans grown at 37°C. One
other notable difference between primary and immortal-
ized bronchial cells was the lack of CEBP/β up regulation
by C. neoformans in NHBE. The precise reasons for these
variations are not known but may be attributable either to
the immortalization and maintenance of the BEAS-2B cell
line or the inherent variability among human donors.
Since the current data is derived from the study of cells
from a single individual, it will be important to confirm
these observations using a larger number of primary
human samples.
In the lung, the inflammatory response of epithelial cells
is likely integrated with alveolar macrophages to rapidly
generate an innate immune response against C. neoform-
ans. In this study, the amplitude of the IL-8 response was
substantial, though relatively limited in comparison to
highly pathogenic bacteria or viruses such as Streptococcus
pneumoniae [39] or influenza virus [40], respectively. This
modest inflammatory activation of the airway epithelium
is consistent with the subtle clinical manifestations that
are characteristic of cryptococcal respiratory tract infection
in humans and may be one mechanism by which crypto-
cocci are able to establish a latent infective state [2]. In
contrast to studies with the A549 alveolar cell line [15,16],
our results indicate that cryptococcal GXM polysaccharide
down-regulates the activation of bronchial epithelial cells.
We speculate that the acute inflammatory response may
be even more limited among immune compromised
hosts, resulting in insufficient airway cellular recruitment
and a predisposition to the development of disseminated
disease. Interestingly, modest IL-8 release was also
recently demonstrated following the interaction of A549
cells with mycelial fragments and spores of Aspergillus
fumigatus [41]. Taken together, these observations suggest
that C. neoformans and perhaps other pathogenic fungi
may escape the pulmonary innate immune response due
to the limited extent of airway epithelial cell activation.
Conclusion
Primary as well as immortalized human bronchial epithe-
lial cells secrete IL-8 and up regulate the expression of
CXCL1 following C. neoformans exposure. In addition,
bronchial epithelial cells are susceptible to damage when
stimulated with cryptococci. Activation and host airway
cell damage appears to be modulated by capsule expres-
sion and the growth temperature of the infecting yeast.
These host responses are very likely to represent an impor-
tant component of the pulmonary innate immunity
against this opportunistic pathogen.
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